Three phase II cytokine working group trials of gp100 (210M) peptide plus high-dose interleukin-2 in patients with HLA-A2-positive advanced melanoma.

Details

Language :

English

ISSN :

0732183X

Volume :

26

Issue :

14

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

105736727

Full Text :

https://doi.org/10.1200/JCO.2007.13.3165